With a robust projected market size of USD 86.16 billion by 2035, the US pharmaceutical contract manufacturing market is emerging as a pivotal player in the healthcare landscape. This growth, driven by a CAGR of 4.56%, signifies the increasing reliance on outsourcing within the pharmaceutical sector. As companies pivot towards specialized manufacturing capabilities, they are met with the...